clinical trial · NCT03653364
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
Hoffmann-La Roche·phase3·completed·n = 49
InfluenzaBaloxavir Marboxil
brief summary
This study will evaluate the safety, pharmacokinetics and efficacy of baloxavir marboxil in healthy pediatric participants from birth to \<1 year with influenza like symptoms
started
Jan 23, 2019
primary completion
Apr 3, 2023
completion
Apr 3, 2023
last updated
May 17, 2024
official title
A Multicenter, Single-Arm, Open-Label Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Otherwise Healthy Pediatric Patients From Birth to < 1 Year With Influenza-Like Symptoms
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol